<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308370">
  <stage>Registered</stage>
  <submitdate>13/08/2009</submitdate>
  <approvaldate>18/08/2009</approvaldate>
  <actrnumber>ACTRN12609000712202</actrnumber>
  <trial_identification>
    <studytitle>Preterm Infant receiving Breast Milk or Glucose for Pain Relief Study (PIMiG Pain Study): a randomised controlled trial.</studytitle>
    <scientifictitle>Preterm Infant receiving Breast Milk or Glucose for Pain Relief Study (PIMiG Pain Study)</scientifictitle>
    <utrn />
    <trialacronym>PIMiG Pain Study</trialacronym>
    <secondaryid>New secondary ID. Please modify.</secondaryid>
    <secondaryid>Breast milk and glucose for pain relief in preterm infants: a noninferiority randomized controlled trial</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pain in neonates related to heel lancing</healthcondition>
    <conditioncode>
      <conditioncode1>Alternative and complementary medicine</conditioncode1>
      <conditioncode2>Other alternative and complementary medicine</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Orally administered expressed breast milk (volume: 2ml), prior to a single heel lance. Heel lance will be performed by using a mechanical device in which a stylet is placed in the spring-loaded cartridge. It takes less than 30 seconds to perform the puncture and blood collection.</interventions>
    <comparator>Orally administered 25% glucose solution (volume: 2ml), prior to a single heel lance</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Premature Infant Pain Profile scores</outcome>
      <timepoint>30 seconds after the painful procedure</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Heart rate (measured by an electrocardiogram (ECG) monitor)</outcome>
      <timepoint>Baseline (15 seconds before the procedure)
After the painful procedure (each 30 seconds after the procedure, during 3 minutes)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Near term neonates</inclusivecriteria>
    <inclusiveminage>12</inclusiveminage>
    <inclusiveminagetype>Hours</inclusiveminagetype>
    <inclusivemaxage>72</inclusivemaxage>
    <inclusivemaxagetype>Hours</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Oral fasting, alteration of swallow or gag reflexes, assisted ventilation, born to mothers who have human immunodeficiency virus (HIV) and/or C hepatitis, born to mothers users of illicit drugs, proven or suspected intracranial hemorrhage grade II or more, neonates who underwent surgery, use of analgesic or sedatives for less than 24 hours before the procedure, proven or suspected necrotizing enterocolitis</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation concealment was achieved by using numbered opaque sealed envelopes containing intervention codes. Envelopes were exclusively accessed by research assistants and contained intervention codes.</concealment>
    <sequence>A statistician used the Statistical Analysis System (SAS), version 8.2 to generate blocked randomization lists. Randomization was stratified according to infantsâ€™ type of feeding (e.g., breast feeding and artificial milk). Rationale for stratification was because of the published effects of breast feeding as an analgesic method for neonatal procedural pain.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Noninferiority randomised controlled trial.</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>7/08/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>86</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>The State of Sao Paulo Research Foundation (FAPESP)</primarysponsorname>
    <primarysponsoraddress>R. Pio XI, 1500 - Alto da Lapa - CEP 05468-901 - Sao Paulo/SP - Brasil</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>The State of Sao Paulo Research Foundation (FAPESP)</fundingname>
      <fundingaddress>R. Pio XI, 1500 - Alto da Lapa - CEP 05468-901 - Sao Paulo/SP - Brasil</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of the study is to compare the use of expressed breast milk and 25% glucose as analgesic strategies for pain relief in preterm neonates. The hypothesis is that breast milk is as effective as glucose.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Comissao de Etica para Analise de Projetos de Pesquisa do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo</ethicname>
      <ethicaddress>Rua Dr. Ovidio Pires de Campos, 225
Cerqueira Cesar - Sao Paulo/SP
05403-010</ethicaddress>
      <ethicapprovaldate>18/07/2008</ethicapprovaldate>
      <hrec>404/08</hrec>
      <ethicsubmitdate>1/04/2008</ethicsubmitdate>
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mariana Bueno</name>
      <address>Rua Itapiru, 224, apto 31
Saude
Sao Paulo, SP, Brazil
04143-010</address>
      <phone>55 11 91367136</phone>
      <fax />
      <email>mariana.bueno@usp.br</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mariana Bueno</name>
      <address>Rua Itapiru, 224, apto 31
Saude
Sao Paulo, SP, Brazil
04143-010</address>
      <phone>55 11 91367136</phone>
      <fax />
      <email>mariana.bueno@usp.br</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>